home / stock / cerc / cerc quote
Last: | $2.93 |
---|---|
Change Percent: | -1.68% |
Open: | $2.98 |
Close: | $2.93 |
High: | $2.98 |
Low: | $2.9 |
Volume: | 266,862 |
Last Trade Date Time: | 08/25/2021 04:41:35 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.93 | $2.98 | $2.93 | $2.98 | $2.9 | 266,862 | 08-25-2021 |
$2.98 | $2.88 | $2.98 | $3 | $2.88 | 401,043 | 08-24-2021 |
$2.89 | $2.82 | $2.89 | $2.93 | $2.7711 | 256,800 | 08-23-2021 |
$2.77 | $2.62 | $2.77 | $2.83 | $2.62 | 376,450 | 08-20-2021 |
$2.65 | $2.8 | $2.65 | $2.8893 | $2.61 | 419,575 | 08-19-2021 |
$2.78 | $2.79 | $2.78 | $2.87 | $2.72 | 207,544 | 08-18-2021 |
$2.79 | $2.73 | $2.79 | $2.81 | $2.6899 | 272,871 | 08-17-2021 |
$2.77 | $2.84 | $2.77 | $2.87 | $2.66 | 421,880 | 08-16-2021 |
$2.87 | $2.92 | $2.87 | $2.9626 | $2.86 | 392,057 | 08-13-2021 |
$2.93 | $3.02 | $2.93 | $3.03 | $2.9 | 407,562 | 08-12-2021 |
$3.06 | $2.96 | $3.06 | $3.06 | $2.88 | 472,972 | 08-11-2021 |
$2.96 | $2.98 | $2.96 | $3.1 | $2.95 | 339,852 | 08-10-2021 |
$3.02 | $2.88 | $3.02 | $3.05 | $2.8302 | 532,098 | 08-09-2021 |
$2.82 | $2.82 | $2.82 | $2.89 | $2.74 | 472,857 | 08-06-2021 |
$2.82 | $2.66 | $2.82 | $2.82 | $2.66 | 404,827 | 08-05-2021 |
$2.68 | $2.67 | $2.68 | $2.76 | $2.61 | 537,893 | 08-04-2021 |
$2.69 | $2.66 | $2.69 | $2.73 | $2.63 | 341,825 | 08-03-2021 |
$2.69 | $2.66 | $2.69 | $2.7899 | $2.65 | 320,474 | 08-02-2021 |
$2.66 | $2.68 | $2.66 | $2.72 | $2.64 | 351,724 | 07-30-2021 |
$2.69 | $2.75 | $2.69 | $2.805 | $2.69 | 301,825 | 07-29-2021 |
News, Short Squeeze, Breakout and More Instantly...
Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026 Executed private placement financing of up to $185 million, including initial upfront invest...
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split of the Company’s common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on December 28, 2023. The Company’...
Annual Meeting has been adjourned until December 20, 2023 Most stockholders can vote via proxyvote.com or by calling 1-800-690-6903. If you have any questions about how to vote, please call 1-800-607-0088 WAYNE, Pa. and ROCKVILLE, Md., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Avalo Thera...